Subsidiary Guarantors Condensed Consolidating Statement of Cash Flows (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ 80.5	$ 267.0
Cash flows from investing activities:
Capital expenditures	(51.8)	(48.1)
Change in restricted cash	0.0
Purchase of marketable securities	(8.5)	(40.1)
Proceeds from sale of marketable securities	5.9	12.2
Investments in affiliates	0.0	0.0
Loans to affiliates	0.0	0.0
Repayments of loans from affiliates	0.0	0.0
Payments for product rights and other, net	(105.6)	(11.5)
Net cash used in investing activities	(160.0)	(87.5)
Cash flows from financing activities:
Payments of financing fees	(31.6)	(22.4)
Change in short-term borrowings, net	65.1	(161.6)
Proceeds from issuance of long-term debt	0.0	100.0
Payments of long-term debt	0.0	(100.0)
Proceeds from exercise of stock options	3.6	67.4
Taxes paid related to net share settlement of equity awards	(6.9)	(31.7)
Capital contribution from affiliates	0.0	0.0
Payments on borrowings from affiliates	0.0	0.0
Proceeds from borrowings from affiliates	0.0	0.0
Other items, net	0.3	39.3
Net cash provided by (used in) financing activities	30.5	(109.0)
Effect of Exchange Rate on Cash and Cash Equivalents	12.4	(18.8)
Net (decrease) increase in cash and cash equivalents	(36.6)	51.7
Cash and cash equivalents — beginning of period	1,236.0	225.5
Cash and cash equivalents — end of period	$ 1,199.4	$ 277.2
Non-cash transactions:
Ordinary shares issued for acquisition	0.0	6,305.8
Eliminations
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ 0.0	$ 0.0
Cash flows from investing activities:
Capital expenditures	0.0	0.0
Change in restricted cash	0.0
Purchase of marketable securities	0.0	0.0
Proceeds from sale of marketable securities	0.0	0.0
Investments in affiliates	11.3	115.7
Loans to affiliates	3,168.8	1,489.7
Repayments of loans from affiliates	(52.2)	2,047.0
Payments for product rights and other, net	0.0	0.0
Net cash used in investing activities	3,127.9	3,652.4
Cash flows from financing activities:
Payments of financing fees	0.0	0.0
Change in short-term borrowings, net	0.0	0.0
Proceeds from issuance of long-term debt		0.0
Payments of long-term debt		0.0
Proceeds from exercise of stock options	0.0	0.0
Taxes paid related to net share settlement of equity awards	0.0	0.0
Capital contribution from affiliates	(11.3)	(115.7)
Payments on borrowings from affiliates	52.2	(1,489.7)
Proceeds from borrowings from affiliates	(3,168.8)	(2,047.0)
Other items, net	0.0	0.0
Net cash provided by (used in) financing activities	(3,127.9)	(3,652.4)
Effect of Exchange Rate on Cash and Cash Equivalents	0.0	0.0
Net (decrease) increase in cash and cash equivalents	0.0	0.0
Cash and cash equivalents — beginning of period	0.0	0.0
Cash and cash equivalents — end of period	0.0	$ 0.0
Non-cash transactions:
Ordinary shares issued for acquisition		0.0
Mylan N.V. (Parent Guarantor)
Cash flows from operating activities:
Net cash (used in) provided by operating activities	(27.1)	$ 1.0
Cash flows from investing activities:
Capital expenditures	0.0	0.0
Change in restricted cash	0.0
Purchase of marketable securities	0.0	0.0
Proceeds from sale of marketable securities	0.0	0.0
Investments in affiliates	0.0	0.0
Loans to affiliates	(3.6)	(16.4)
Repayments of loans from affiliates	32.8	0.0
Payments for product rights and other, net	0.0	0.0
Net cash used in investing activities	29.2	(16.4)
Cash flows from financing activities:
Payments of financing fees	(31.6)	0.0
Change in short-term borrowings, net	0.0	0.0
Proceeds from issuance of long-term debt		0.0
Payments of long-term debt		0.0
Proceeds from exercise of stock options	3.6	0.0
Taxes paid related to net share settlement of equity awards	(6.9)	0.0
Capital contribution from affiliates	0.0	0.0
Payments on borrowings from affiliates	0.0	0.0
Proceeds from borrowings from affiliates	31.6	0.0
Other items, net	1.2	15.4
Net cash provided by (used in) financing activities	(2.1)	15.4
Effect of Exchange Rate on Cash and Cash Equivalents	0.0	0.0
Net (decrease) increase in cash and cash equivalents	0.0	0.0
Cash and cash equivalents — beginning of period	0.0	0.0
Cash and cash equivalents — end of period	0.0	$ 0.0
Non-cash transactions:
Ordinary shares issued for acquisition		0.0
Mylan Inc. (Issuer)
Cash flows from operating activities:
Net cash (used in) provided by operating activities	(139.4)	$ (555.8)
Cash flows from investing activities:
Capital expenditures	(20.6)	(9.5)
Change in restricted cash	0.0
Purchase of marketable securities	(0.5)	0.0
Proceeds from sale of marketable securities	0.0	0.0
Investments in affiliates	(11.3)	(115.7)
Loans to affiliates	(1,465.6)	(1,473.3)
Repayments of loans from affiliates	12.2	0.0
Payments for product rights and other, net	(0.1)	0.0
Net cash used in investing activities	(1,485.9)	(1,598.5)
Cash flows from financing activities:
Payments of financing fees	0.0	(22.4)
Change in short-term borrowings, net	0.0	0.0
Proceeds from issuance of long-term debt		100.0
Payments of long-term debt		(100.0)
Proceeds from exercise of stock options	0.0	67.4
Taxes paid related to net share settlement of equity awards	0.0	(29.4)
Capital contribution from affiliates	0.0	0.0
Payments on borrowings from affiliates	(40.0)	15.4
Proceeds from borrowings from affiliates	1,703.2	2,047.0
Other items, net	0.0	23.9
Net cash provided by (used in) financing activities	1,663.2	2,101.9
Effect of Exchange Rate on Cash and Cash Equivalents	0.0	0.0
Net (decrease) increase in cash and cash equivalents	37.9	(52.4)
Cash and cash equivalents — beginning of period	870.5	112.9
Cash and cash equivalents — end of period	908.4	$ 60.5
Non-cash transactions:
Ordinary shares issued for acquisition		6,305.8
Guarantor Subsidiaries
Cash flows from operating activities:
Net cash (used in) provided by operating activities	0.0	$ 0.0
Cash flows from investing activities:
Capital expenditures	0.0	0.0
Change in restricted cash	0.0
Purchase of marketable securities	0.0	0.0
Proceeds from sale of marketable securities	0.0	0.0
Investments in affiliates	0.0	0.0
Loans to affiliates	0.0	0.0
Repayments of loans from affiliates	0.0	0.0
Payments for product rights and other, net	0.0	0.0
Net cash used in investing activities	0.0	0.0
Cash flows from financing activities:
Payments of financing fees	0.0	0.0
Change in short-term borrowings, net	0.0	0.0
Proceeds from issuance of long-term debt		0.0
Payments of long-term debt		0.0
Proceeds from exercise of stock options	0.0	0.0
Taxes paid related to net share settlement of equity awards	0.0	0.0
Capital contribution from affiliates	0.0	0.0
Payments on borrowings from affiliates	0.0	0.0
Proceeds from borrowings from affiliates	0.0	0.0
Other items, net	0.0	0.0
Net cash provided by (used in) financing activities	0.0	0.0
Effect of Exchange Rate on Cash and Cash Equivalents	0.0	0.0
Net (decrease) increase in cash and cash equivalents	0.0	0.0
Cash and cash equivalents — beginning of period	0.0	0.0
Cash and cash equivalents — end of period	0.0	$ 0.0
Non-cash transactions:
Ordinary shares issued for acquisition		0.0
Non-Guarantor Subsidiaries
Cash flows from operating activities:
Net cash (used in) provided by operating activities	247.0	$ 821.8
Cash flows from investing activities:
Capital expenditures	(31.2)	(38.6)
Change in restricted cash	0.0
Purchase of marketable securities	(8.0)	(40.1)
Proceeds from sale of marketable securities	5.9	12.2
Investments in affiliates	0.0	0.0
Loans to affiliates	(1,699.6)	0.0
Repayments of loans from affiliates	7.2	(2,047.0)
Payments for product rights and other, net	(105.5)	(11.5)
Net cash used in investing activities	(1,831.2)	(2,125.0)
Cash flows from financing activities:
Payments of financing fees	0.0	0.0
Change in short-term borrowings, net	65.1	(161.6)
Proceeds from issuance of long-term debt		0.0
Payments of long-term debt		0.0
Proceeds from exercise of stock options	0.0	0.0
Taxes paid related to net share settlement of equity awards	0.0	(2.3)
Capital contribution from affiliates	11.3	115.7
Payments on borrowings from affiliates	(12.2)	1,474.3
Proceeds from borrowings from affiliates	1,434.0	0.0
Other items, net	(0.9)	0.0
Net cash provided by (used in) financing activities	1,497.3	1,426.1
Effect of Exchange Rate on Cash and Cash Equivalents	12.4	(18.8)
Net (decrease) increase in cash and cash equivalents	(74.5)	104.1
Cash and cash equivalents — beginning of period	365.5	112.6
Cash and cash equivalents — end of period	$ 291.0	$ 216.7
Non-cash transactions:
Ordinary shares issued for acquisition		0.0